Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Background: This study evaluated the cost-utility of telephone-based cognitive behavioral therapy (TB-CBT) (experimental arm) in comparison with a placebo-befriending (control arm) program in COPD participants with mild to severe depression and/or anxiety. Methods: The decision rule was based on willingness-to-pay if there is an increased unit of effectiveness (a quality-adjusted life year [QALY] gain) and an increase in cost, and willingness-to-accept (WTA) if there is a reduced unit of effectiveness (a QALY loss) and decrease in cost (a cost-saving). Results: TB-CBT group was associated with a reduction in the incremental cost of AUS−$407.3 (p < 0.001, SE:34.1) plus a negative, nonsignificant incremental QALY gain of −0.008 (SE:0.011) per patient compared to control group. The point estimate of the mean incremental cost-utility ratio was AUS$50,284.0 cost saving per QALY sacrificed (the high value associated with small QALY value in the denominator). Ninety-five percent CI was AUS$13,426 cost sacrificed to AUS$32,018 cost gain (lower values associated with larger QALY values in the denominator). If the societal’s minimum (flooring threshold) WTA is AUS$64,000 per QALY forgone, the probability of TB-CBT being cost-effective was 42% Conclusions: This study showed that TB-CBT can be recommended as a cost-saving and preventive approach over usual care plus befriending program. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Prospect Theory: An Analysis of Decision under Risk
Kahneman, D., & Tversky, A. (1979) · Econometrica · doi:10.2307/1914185 · Cited by 48,524
Methods for the economic evaluation of health care programmes
Wilson, S. H. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,275 · cited 1×
“The estimated HSUV-AQoL-4D were used to calculate QALYs by using the area under the curve method [28].”
MethodCost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Hawthorne, G., Richardson, J., & Osborne, R. (1999) · Quality of Life Research · doi:10.1023/a:1008815005736 · Cited by 786
Anxiety and Depression in COPD
Maurer, J., Rebbapragada, V., Borson, S., Goldstein, R., Kunik, M. E., Yohannes, A. M., & Hanania, N. A. (2008) · Chest · doi:10.1378/chest.08-0342 · Cited by 720
Shiroiwa, T., Sung, Y., Fukuda, T., Lang, H., Bae, S., & Tsutani, K. (2010) · Health Economics · doi:10.1002/hec.1481 · Cited by 690 · cited 2×
“We used Shiroiwa et al’s study [36] to define the threshold for cost-utility analysis in this study.”
MethodResultFaria, R., Gomes, M., Epstein, D., & White, I. R. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0193-3 · Cited by 673
Consolidated health economic evaluation reporting standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.010 · Cited by 657
Yohannes, A. M., Willgoss, T. G., Baldwin, R. C., & Connolly, M. J. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2463 · Cited by 476 · cited 1×
“The reported prevalence rates are between 8%–80% for depression and 6%–75% for anxiety in COPD patients [1,4].”
Background
Research works printed but not linked: 3
- Cafarella PA, 2013, Eur Respir Monogr, 59, 144
- Doyle C, 2016, Int J Chron Obstruct Pulmon Dis, 11, 327
- Hoffman E, 1993, Wash Univ Law Q, 71, 59
Cited by
Rohrbach, P. J., Dingemans, A. E., Evers, C., van Furth, E. F., Spinhoven, P., Aardoom, J. J., Lähde, I., Clemens, F. C., & Marle, M. E. V. D. A. (2022) · Journal of Medical Internet Research · doi:10.2196/38204 · Cited by 66
“Dixon et al [48], Duarte et al [49], Lovell et al [64], Moayeri et al [65], and van Luenen et al [74] 5 Telephone support”
BackgroundInfluentialNonpharmacological management of psychological distress in people with COPD
Volpato, E., Farver-Vestergaard, I., Brighton, L. J., Peters, J. B., Verkleij, M., Hutchinson, A., Heijmans, M., & von Leupoldt, A. (2023) · European Respiratory Review · doi:10.1183/16000617.0170-2022 · Cited by 64
Virtual Care Initiatives for Older Adults in Australia: Scoping Review
Savira, F., Gupta, A., Gilbert, C. A., Huggins, C. E., Browning, C. J., Chapman, W. W., Haines, T. P., & Peeters, A. (2022) · Journal of Medical Internet Research · doi:10.2196/38081 · Cited by 30
“Telephone initiatives were used predominantly for education, follow-up evaluation, and care support (n=20) [47,50,54,58-62,97-103,105,107,109-113].”
BackgroundMethodPumar, M., Roll, M., Fung, P., Rolls, T., Walsh, J., Bowman, R., Fong, K. M., & Yang, I. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.23 · Cited by 28
Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review
Williams, M., Johnston, K., & Paquet, C. (2020) · International Journal of COPD · doi:10.2147/copd.s178049 · Cited by 57
Metadata
- Authors
- Moayeri, F., Dunt, D., Hsueh, Y.-S. (., & Doyle, C.
- Affiliations
- The University of Melbourne (AU)
- Australian Catholic University (AU)
- Corresponding author
- Moayeri, Foruhar
- Venue
- Expert Review of Pharmacoeconomics & Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2018-10-19
- Volume
- 19
- Issue
- 3
- Pages
- 331-340
- ISSN
- 1473-7167 (ISSN-L)
- 1744-8379
- OpenAlex
- W2896984381
- Cited by
- 15
- References
- 44
- Citations by year
- 2026: 2 · 2023: 4 · 2022: 6 · 2020: 2 · 2019: 1
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- Locations
- Expert Review of Pharmacoeconomics & Outcomes Research (publishedVersion)
- PubMed (publishedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Figshare (cc-by)
- Funders
- Beyondblue
- National Ageing Research Institute (NARI)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- chronic obstructive pulmonary disease, depression, anxiety, comorbidities, willingness to accept, cost-utility analysis, cost-effectiveness, quality-adjusted life years
- MeSH terms
- Aged, Anxiety, Cost-Benefit Analysis, Depression, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Severity of Illness Index, Telephone, Cognitive Behavioral Therapy, Treatment Outcome, Cost Savings, Quality-Adjusted Life Years, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept. https://app.cochat.ai/papers/10.1080/14737167.2019.1536550
- The paper
- Moayeri, F., Dunt, D., Hsueh, Y.-S. (., & Doyle, C. (2019). Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2019.1536550
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.